Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Daniëlle VerverD van KlaverenV FrankeA C J van AkkooiP RutkowskiU KeilholzA M M EggermontT NijstenD J GrünhagenC VerhoefPublished in: The British journal of surgery (2018)
A nomogram for predicting recurrence and MSM in patients with melanoma and negative SNs was constructed and validated. It could provide personalized estimates useful for tailoring surveillance strategies (reduce or increase intensity), and selection of patients for adjuvant therapy or clinical trials.
Keyphrases
- clinical trial
- lymph node
- end stage renal disease
- ejection fraction
- lymph node metastasis
- newly diagnosed
- public health
- free survival
- wastewater treatment
- squamous cell carcinoma
- men who have sex with men
- high intensity
- type diabetes
- risk factors
- prognostic factors
- randomized controlled trial
- skin cancer
- patient reported outcomes
- human immunodeficiency virus
- rectal cancer
- antiretroviral therapy
- phase iii